📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cardioxyl

1.1 - Company Overview

Cardioxyl Logo

Cardioxyl

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical research and development focused on discovering, developing and commercializing novel therapies for cardiovascular disease, targeting areas where current treatments do not exist, are ineffective or inadequate.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cardioxyl

Tricares Logo

Tricares

HQ: France Website
  • Description: Provider of minimally invasive, catheter-based tricuspid valve replacement solutions for tricuspid valve regurgitation, featuring the Topaz Transfemoral Tricuspid Valve Replacement (TTVR) system for transfemoral native valve replacement, the self-expanding biological Topaz Heart Valve Prosthesis, and the Topaz Implantation System for steerable venous access and prosthesis delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tricares company profile →
Cardiol Therapeutics Logo

Cardiol Therapeutics

HQ: Canada Website
  • Description: Provider of cannabidiol-based therapies for heart disease, including CardiolRx, an oral solution in clinical development to inhibit inflammatory pathways; CRD-38, a subcutaneous formulation for heart failure aiming to improve pharmacokinetics and therapeutic efficacy; and Phase II studies MAvERIC-Pilot (recurrent pericarditis) and ARCHER (acute myocarditis) evaluating safety, tolerability, efficacy, and impact on myocardial recovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardiol Therapeutics company profile →
Huyabio Logo

Huyabio

HQ: United States Website
  • Description: Provider of novel biopharmaceutical product opportunities, including HBI-8000, an oral class I selective HDAC inhibitor for cancers; HBI-3000, a multi-ion channel blocker for atrial fibrillation; HBI-2376, an SHP2 inhibitor for solid tumors; HBI-ONC, an epigenetic inhibitor for MDS/AML; and HBI-3800, a small molecule to regenerate cardiac muscle damaged by ischemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Huyabio company profile →
LifeWatch Logo

LifeWatch

HQ: Switzerland Website
  • Description: Provider of remote cardiac monitoring and digital health solutions, offering wireless remote diagnostic patient monitoring services that deliver critical data for treatment decisions. Solutions include Philips Mobile Cardiac Telemetry (MCOT), Philips ePatch Extended Holter, Implantable Device Monitoring, EMR Integration, Telehealth Home Connect for at-home monitor application, and Remote INR patient self-testing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LifeWatch company profile →
HeartWare Logo

HeartWare

HQ: United States Website
  • Description: Provider of small implantable heart pumps and ventricular assist devices for treating advanced heart failure, offering the HeartWare Ventricular Assist System with LVAD/blood pump, patient accessories, and surgical tools. Products include the Medtronic HVAD System for less-invasive thoracotomy, destination therapy and bridge to transplant, plus HVAD Waveforms, controller logfiles, Autologs, and HVAD patient resources.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HeartWare company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cardioxyl

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cardioxyl

2.2 - Growth funds investing in similar companies to Cardioxyl

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cardioxyl

4.2 - Public trading comparable groups for Cardioxyl

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cardioxyl

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cardioxyl

What does Cardioxyl do?

Cardioxyl is a provider of clinical-stage biopharmaceutical research and development focused on discovering, developing and commercializing novel therapies for cardiovascular disease, targeting areas where current treatments do not exist, are ineffective or inadequate.

Who are Cardioxyl's competitors?

Cardioxyl's competitors and similar companies include Tricares, Cardiol Therapeutics, Huyabio, LifeWatch, and HeartWare.

Where is Cardioxyl headquartered?

Cardioxyl is headquartered in United States.

How many employees does Cardioxyl have?

Cardioxyl has 1,000 employees 🔒.

When was Cardioxyl founded?

Cardioxyl was founded in 2010 🔒.

What sector and industry vertical is Cardioxyl in?

Cardioxyl is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cardioxyl

Who are the top strategic acquirers in Cardioxyl's sector and industry

Top strategic M&A buyers and acquirers in Cardioxyl's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cardioxyl?

Top strategic M&A buyers groups and sectors for Cardioxyl include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cardioxyl's sector and industry vertical

Which are the top PE firms investing in Cardioxyl's sector and industry vertical?

Top PE firms investing in Cardioxyl's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cardioxyl's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cardioxyl's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cardioxyl's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cardioxyl include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cardioxyl's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cardioxyl?

The key public trading comparables and valuation benchmarks for Cardioxyl include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cardioxyl for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cardioxyl with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cardioxyl's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cardioxyl with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cardioxyl's' sector and industry vertical?

Access recent funding rounds and capital raises in Cardioxyl's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cardioxyl